Electroconvulsive therapy and/or plasmapheresis in autoimmune encephalitis?

Area of Science:

• Neuroimmunology
• Psychiatry
• Neurology

Background:

• Autoimmune encephalitis is a complex neurological disorder characterized by neurological and psychiatric symptoms, often associated with autoantibodies.
• Anti-N-Methyl-D-Aspartate receptor (NMDAR) encephalitis is the most common form, typically treated with plasmapheresis, steroids, and immunosuppression.
• Standard treatments may be insufficient for patients with severe, refractory psychiatric manifestations.

Observation:

• Case reports and a new case study investigated the efficacy of electroconvulsive therapy (ECT) in autoimmune encephalitis patients with debilitating psychiatric symptoms.
• Patients, particularly those with anti-NMDAR encephalitis, experienced severe catatonia, psychosis, and stupor unresponsive to conventional treatments.
• A 71-year-old female with anti-NMDAR encephalitis showed complete resolution of depression, catatonia, delusions, and hallucinations after ECT, returning to her premorbid state.

Findings:

• Electroconvulsive therapy (ECT) demonstrated significant effectiveness in managing severe psychiatric symptoms in autoimmune encephalitis cases refractory to standard therapies.
• ECT was particularly beneficial for patients with anti-NMDAR encephalitis, resolving symptoms like catatonia and psychosis.
• The study suggests a potential role for ECT in improving outcomes for non-responders to established treatments.

Implications:

• ECT should be considered as a therapeutic option for autoimmune encephalitis patients, especially those with severe psychiatric symptoms unresponsive to standard treatments.
• Further research into the mechanisms of ECT's efficacy in autoimmune encephalitis is warranted.
• Early consideration of ECT may improve patient outcomes and facilitate recovery from debilitating neurological and psychiatric manifestations.